Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brymill Cryogenic Systems is a private medical device company focused on handheld liquid nitrogen cryosurgical and cryospray equipment for dermatology, podiatry, veterinary, and related clinical uses. The company manufactures and sells commercial cryosurgery devices including the Cry-Ac, Cry-Ac-3, and Cry-Baby product lines, along with probes, sprays, accessories, and liquid nitrogen handling equipment. Brymill emphasizes U.S.-based manufacturing, long operating history, and regulatory compliance for its cryosurgical product portfolio. Its products are used by physicians and other healthcare providers to treat common skin lesions and perform office-based cryotherapy procedures. The business appears to be an established niche healthcare equipment manufacturer rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brymill Cryogenic Systems.